<!DOCTYPE html>
<html>
<head>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="">
    <meta name="description" content="">
    <title>详细报告语句详情</title>
    <link href="../css/bootstrap.css" rel="stylesheet" />
    <link href="../css/style.css" rel="stylesheet" />
    <style type="text/css">
        .content-tips .paper-section{margin-bottom:0;min-width:450px;}
    </style>
</head>
<body>
<span id="gototop"></span>
<div>
    <div class="paper-txt P30">
        <div class="paper-section" style="margin-bottom:0;">
            <div class="font-bold MT5">
                该句相似度：<span class="g-font-color orange similarNum">57%</span>
            </div>
            <div class="MT30">
                <p class="font-bold">您的语句：</p>
                <span>回顾性分析替吉奥单药或联合用药在复发性宫颈癌治疗中的疗效及安全性。</span>
            </div>
        </div>
    </div>
    <div>
        <div class="tab-A">
            <ul class="tab-A-ul clearfix" tab-a="ul">
                <li class="active" data-id="学术期刊,学位论文,学术会议,书籍数据,互联网,自建库,all">
                    <span class="tab-text">综合</span>
                    <span class="tab-superscript">8</span>
                </li>
                <li data-id="tab,学术期刊,学位论文,学术会议,书籍数据,自建库,local">
                    <span class="tab-text">本地库</span>
                    <span class="tab-superscript">8</span>
                </li>
                <li data-id="互联网,5">
                    <span class="tab-text">互联网</span>
                    <span class="tab-superscript">0</span>
                </li>
            </ul>
        </div>
        <div class="none" tab="section" data-id="tab">
            <div class="tab-B clearfix">
                <div class="paper-section P30 PB0 clearfix">
                    <span class="tab-B-span pull-left">本地库</span>
                    <ul class="tab-B-ul pull-left clearfix" tab-b="ul">
                        <li class="active" data-id="tab,学术期刊,学位论文,学术会议,书籍数据,自建库,local">
                            <span class="tab-text">全部</span>
                            <span class="tab-superscript">8</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,学术期刊,1">
                            <span class="tab-text">期刊</span>
                            <span class="tab-superscript">3</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,学位论文,2">
                            <span class="tab-text">学位</span>
                            <span class="tab-superscript">5</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,学术会议,3">
                            <span class="tab-text">会议</span>
                            <span class="tab-superscript">0</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,书籍数据,4">
                            <span class="tab-text">图书</span>
                            <span class="tab-superscript">0</span>
                                                    </li>
                                            </ul>
                </div>
                <div class="g-line-row MT30 tab-pane-line"></div>
            </div>
        </div>
        <div class="content-tips">
            <div class="tab-content none" tab="section" data-id="1">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在期刊库共找出相似内容：<span>3</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>
                    </div>
                </div>
            </div>

            <div class="tab-content none" tab="section" data-id="2">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在学位库共找出相似内容：<span>5</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>                    </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="3">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在会议库中没有找到与此句话相似的内容                    <p>
                    <div class="pull-right">
                                            </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="4">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在图书库中没有找到与此句话相似的内容                    <p>
                    <div class="pull-right">
                                            </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="5">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在互联网库中没有找到与此句话相似的内容                    <p>
                    <div class="pull-right">
                                            </div>
                </div>
            </div>
            <!-- 自建库 -->
            <div class="tab-content none" tab="section" data-id="6">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在自建库中没有找到与此句话相似的内容                    <p>
                    <div class="pull-right">
                                            </div>
                </div>
            </div>
                        <div class="tab-content" tab="section" data-id="all">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在本地库和互联网库共找出相似内容：<span>8</span>个
                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>

                    </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="local">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在本地库共找出相似内容：<span>8</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>
                    </div>
                </div>
            </div>
        </div>



                <div class="tab-content" tab="section" data-id="学术期刊">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">1</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">57%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">回顾<span class="g-underline-text">性</span>分析<span class="g-underline-text">替</span>吉奥<span class="g-underline-text">单</span>药或<span class="g-underline-text">联合</span>用药<span class="g-underline-text">在</span><span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span><span class="g-underline-text">癌</span><span class="g-underline-text">治疗</span><span class="g-underline-text">中</span><span class="g-underline-text">的</span><span class="g-underline-text">疗效</span><span class="g-underline-text">及</span><span class="g-underline-text">安全</span><span class="g-underline-text">性</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">联合</span>拓扑<span class="g-underline-text">替</span>康<span class="g-underline-text">及</span>贝伐<span class="g-underline-text">单</span>抗<span class="g-underline-text">在</span><span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span><span class="g-underline-text">癌</span><span class="g-underline-text">中</span><span class="g-underline-text">治疗</span><span class="g-underline-text">的</span><span class="g-underline-text">疗效</span><span class="g-underline-text">及</span><span class="g-underline-text">安全</span><span class="g-underline-text">性</span>。</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            患者放化疗的同时联合贝伐单抗治疗是安全有效的，因为研究患者数量的局限，仍需进一步扩大样本量研究[”】。另一项II期临床试验GSKl07278研究了顺铂<span class="g-font-color green">联合拓扑替康及贝伐单抗在复发性宫颈癌中治疗的疗效及安全性。</span>患者中位缓解期为4．4个月，中位无进展生存期为7．1个月                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术期刊）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《宫颈癌的靶向药物治疗研究进展》<br><b>作者：</b>甘露 魏明 寻倩 侯春丽 陈丽宏<br><b>作者单位：</b>陕西省人民医院妇科,西安,710068；西安医学院基础医学部药理毒理学教研室,西安,710021<br><b>参考文献：</b>20篇<br><b>页码：</b>P154—P156,183<br><b>页数：</b>4页<br><b>分类号：</b>R979.1<br><b>基金项目：</b>陕西省自然科学基础研究计划项目(2014JQ2-8055);陕西省教育厅专项科研计划项目(14JK1622);西安医学院校级科研计划扶植项目(12FZ16)<br><b>期刊名称：</b>《国外医药（抗生素分册）》<br><b>出版时间：</b>2015年4期<br><b>ISSN：</b>1001-8751<br><b>关键词：</b>宫颈癌 靶向药物 进展<br><b>摘要：</b>宫颈癌是妇科最常见恶性肿瘤之一,随着分子生物学的发展,在局部晚期宫颈癌患者的治疗中的靶向治疗药物不断涌现.宫颈癌的靶向治疗已经成为目前研究的热点.本文对宫颈癌的靶向药物治疗研究进展作一综述,为指导宫颈癌临床用药提供基础.
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术期刊">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">2</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">47%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange"><span class="g-underline-text">回顾</span><span class="g-underline-text">性</span><span class="g-underline-text">分析</span><span class="g-underline-text">替</span><span class="g-underline-text">吉</span><span class="g-underline-text">奥</span><span class="g-underline-text">单</span><span class="g-underline-text">药</span><span class="g-underline-text">或</span><span class="g-underline-text">联合</span>用<span class="g-underline-text">药</span>在复发<span class="g-underline-text">性</span>宫颈癌<span class="g-underline-text">治疗</span>中<span class="g-underline-text">的</span>疗效及安全<span class="g-underline-text">性</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">回顾</span><span class="g-underline-text">性</span><span class="g-underline-text">分析</span>收治<span class="g-underline-text">的</span>行<span class="g-underline-text">替</span><span class="g-underline-text">吉</span><span class="g-underline-text">奥</span><span class="g-underline-text">单</span><span class="g-underline-text">药</span><span class="g-underline-text">或</span><span class="g-underline-text">替</span><span class="g-underline-text">吉</span><span class="g-underline-text">奥</span><span class="g-underline-text">联合</span><span class="g-underline-text">吉</span>西他滨一线<span class="g-underline-text">治疗</span><span class="g-underline-text">的</span>晚期胰腺</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            !替吉奥单药及其联合吉西他滨治疗晚期胰腺癌的临床观察周丽娜王李强徐海源计张奕唐敏陈敏斌【摘要】目的探讨替吉奥治疗晚期胰腺癌的临床疗效和安全性。方法<span class="g-font-color green">回顾性分析收治的行替吉奥单药或替吉奥联合吉西他滨一线治疗的晚期胰腺</span>癌患者46例，其中替吉奥组(A组)24例，替吉奥联合吉西他滨组                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术期刊）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《替吉奥单药及其联合吉西他滨治疗晚期胰腺癌的临床观察》<br><b>作者：</b>周丽娜 王李强 徐海源 计张奕 唐敏 陈敏斌<br><b>作者单位：</b>215300,江苏大学附属昆山市第一人民医院肿瘤科<br><b>参考文献：</b>10篇<br><b>页码：</b>P328—P331<br><b>页数：</b>4页<br><b>基金项目：</b>江苏省自然科学基金面上项目(BK2011374);江苏省“六大人才高峰”项目(WSN-012)<br><b>期刊名称：</b>《肿瘤研究与临床》<br><b>出版时间：</b>2015年5期<br><b>期刊级别：</b>ISTIC<br><b>ISSN：</b>1006-9801<br><b>关键词：</b>胰腺肿瘤 替吉奥 吉西他滨<br><b>摘要：</b>目的 探讨替吉奥治疗晚期胰腺癌的临床疗效和安全性.方法 回顾性分析收治的行替吉奥单药或替吉奥联合吉西他滨一线治疗的晚期胰腺癌患者46例,其中替吉奥组(A组)24例,替吉奥联合吉西他滨组(B组)22例,分析两组患者的近期疗效、疾病进展时间、生存期及安全性.结果 A组的客观缓解率、疾病控制率、中位无进展生存期、中位总生存期、1年生存率分别为20.8％(5/24)、66.7 ％(16/24)、4.8个月、9.6个月、12.5％,B组分别为27.3 ％(6/22)、72.7％(16/22)、5.9个月、10.3个月、22.7％,A组的客观缓解率、疾病控制率、中位无进展生存期、中位总生存期、1年生存率均略低于B组,但差异均无统计学意义(均P＞0.05).全组患者不良反应较轻,无治疗相关的死亡事件发生,A组患者的不良反应大部分小于B组,其中A组的白细胞减少、中性粒细胞减少、血小板减少发生率低于B组(P＜0.05).结论 替吉奥单药或联合吉西他滨治疗晚期胰腺癌疗效无差别,但替吉奥单药组不良反应较小,可作为一线治疗.
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">3</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">44%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">回顾<span class="g-underline-text">性</span>分析<span class="g-underline-text">替</span>吉奥<span class="g-underline-text">单</span><span class="g-underline-text">药</span><span class="g-underline-text">或</span>联合用<span class="g-underline-text">药</span><span class="g-underline-text">在</span><span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span>癌<span class="g-underline-text">治疗</span><span class="g-underline-text">中</span><span class="g-underline-text">的</span>疗效及安全<span class="g-underline-text">性</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">一项研究厄洛<span class="g-underline-text">替</span>尼<span class="g-underline-text">单</span><span class="g-underline-text">药</span><span class="g-underline-text">治疗</span><span class="g-underline-text">在</span>耐<span class="g-underline-text">药</span><span class="g-underline-text">性</span><span class="g-underline-text">或</span><span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span>鳞癌<span class="g-underline-text">治疗</span><span class="g-underline-text">的</span>II期临床试验<span class="g-underline-text">中</span></p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            干燥及胰腺炎。对马妥珠单抗在宫颈癌中的作用还需进一步临床试验证实。FDA批准厄洛替尼治疗肺癌，及与吉西他滨联合用于胰腺癌的一线治疗。在<span class="g-font-color green">一项研究厄洛替尼单药治疗在耐药性或复发性宫颈鳞癌治疗的II期临床试验中</span>，其疗效不明显【46】。在一项研究厄洛替尼联合顺铂及放疗在局部晚期宫颈                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《跨损伤DNA合成通路基因REV3L在宫颈癌细胞化疗增敏中的作用及其机制研究》<br><b>作者：</b>杨莉<br><b>分类号：</b>R730.53<br><b>学科专业：</b>肿瘤学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>程玺<br><b>学位授予单位：</b>复旦大学<br><b>学位年度：</b>2014<br><b>关键词：</b>宫颈癌 跨损伤DNA合成 DNA聚合酶 REV3L基因 化疗增敏 分子靶点
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">4</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">44%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">回顾<span class="g-underline-text">性</span>分析替吉奥单药或<span class="g-underline-text">联合</span>用药<span class="g-underline-text">在</span><span class="g-underline-text">复发</span><span class="g-underline-text">性</span>宫颈<span class="g-underline-text">癌</span><span class="g-underline-text">治疗</span><span class="g-underline-text">中</span><span class="g-underline-text">的</span>疗效及安全<span class="g-underline-text">性</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">时间为4．9个月。二、<span class="g-underline-text">联合</span>化疗<span class="g-underline-text">在</span><span class="g-underline-text">复发</span><span class="g-underline-text">性</span>官颈<span class="g-underline-text">癌</span><span class="g-underline-text">治疗</span><span class="g-underline-text">的</span><span class="g-underline-text">中</span>进展因为单药</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            2剂量的吉西他滨周疗(连续化疗3周，而后停药1周)，其总有效率仅为8%，中位无进展生存时间为1．9个月，中位总生存<span class="g-font-color green">时间为4．9个月。二、联合化疗在复发性官颈癌治疗的中进展因为单药</span>化疗在复发性宫颈癌中的疗效有限，而铂类为复发性宫颈癌化疗的最有效药物之一                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《新辅助化疗对局部肿块大于3cm的IIA期宫颈癌患者疗效的探究》<br><b>作者：</b>朱晓庆<br><b>分类号：</b>R730.58<br><b>学科专业：</b>妇产科学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>周建维<br><b>学位授予单位：</b>浙江大学<br><b>学位年度：</b>2015<br><b>关键词：</b>宫颈肿瘤 手术切除 淋巴结清扫 新辅助化疗
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">5</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">41%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">回顾<span class="g-underline-text">性</span>分析替吉奥单药或联合用药在<span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span><span class="g-underline-text">癌</span><span class="g-underline-text">治疗</span>中<span class="g-underline-text">的</span><span class="g-underline-text">疗效</span>及安全<span class="g-underline-text">性</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span><span class="g-underline-text">癌</span>患者<span class="g-underline-text">的</span><span class="g-underline-text">治疗</span><span class="g-underline-text">疗效</span>。单药<span class="g-underline-text">治疗</span><span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span><span class="g-underline-text">癌</span>没有表现出明显<span class="g-underline-text">的</span><span class="g-underline-text">疗效</span>，其中4</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            或E6/E7病毒基因的介导来阻止宫颈癌细胞增殖，从而促进表达E6/E7的肿瘤细胞凋亡。Shilder等人[17]评估了厄洛替尼单药治疗25例<span class="g-font-color green">复发性宫颈癌患者的治疗疗效。单药治疗复发性宫颈癌没有表现出明显的疗效，其中4</span>例（16%）病情稳定，1例（4%）表现了无进展生存期(PFS)超过6                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《宫颈癌分子靶向药物研究及临床应用进展》<br><b>作者：</b>邵均均<br><b>学科专业：</b>肿瘤学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>李胜泽<br><b>学位授予单位：</b>蚌埠医学院<br><b>学位年度：</b>2016
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">6</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">41%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">回顾<span class="g-underline-text">性</span>分析<span class="g-underline-text">替</span>吉奥<span class="g-underline-text">单</span>药<span class="g-underline-text">或</span><span class="g-underline-text">联合</span>用药在<span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span><span class="g-underline-text">癌</span><span class="g-underline-text">治疗</span>中<span class="g-underline-text">的</span>疗效<span class="g-underline-text">及</span><span class="g-underline-text">安全</span><span class="g-underline-text">性</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">拓扑<span class="g-underline-text">替</span>康<span class="g-underline-text">联合</span>贝伐<span class="g-underline-text">单</span>抗<span class="g-underline-text">治疗</span><span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">或</span>难治<span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span><span class="g-underline-text">癌</span>患者<span class="g-underline-text">的</span>有效<span class="g-underline-text">性</span><span class="g-underline-text">及</span><span class="g-underline-text">安全</span><span class="g-underline-text">性</span>，</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            得了一定疗效，近两年关注贝伐单抗治疗复发性或转移性宫颈癌的疗效的相关研究正在逐渐增多。Zighelboim[29]等人进行一项多中心II期临床研究，评估应用顺铂、<span class="g-font-color green">拓扑替康联合贝伐单抗治疗复发性或难治性宫颈癌患者的有效性及安全性，</span>入组27例患者，万方数据兰州大学硕士学位论文腹腔镜下根治性子宫切除术治疗宫颈癌的                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《腹腔镜下根治性子宫切除术治疗宫颈癌的Meta分析》<br><b>作者：</b>杜文静<br><b>分类号：</b>R730.56<br><b>学科专业：</b>临床医学、妇产科学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>杨永秀<br><b>学位授予单位：</b>兰州大学<br><b>学位年度：</b>2016<br><b>关键词：</b>宫颈肿瘤 手术治疗 腹腔镜术 Meta分析
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术期刊">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">7</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">41%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">回顾<span class="g-underline-text">性</span>分析替吉奥单药或<span class="g-underline-text">联合</span>用药在<span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span><span class="g-underline-text">癌</span><span class="g-underline-text">治疗</span>中<span class="g-underline-text">的</span><span class="g-underline-text">疗效</span><span class="g-underline-text">及</span><span class="g-underline-text">安全</span><span class="g-underline-text">性</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">吴方红，文静，等.紫杉醇<span class="g-underline-text">联合</span>卡铂<span class="g-underline-text">治疗</span>晚期与<span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span><span class="g-underline-text">癌</span><span class="g-underline-text">的</span><span class="g-underline-text">疗效</span><span class="g-underline-text">及</span><span class="g-underline-text">安全</span><span class="g-underline-text">性</span>.</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            ，值得借鉴。参考文献[1]刘少晓，程晓燕，郑红枫，等.紫杉醇联合顺铂新辅助治疗局部晚期宫颈癌的临床疗效及安全性评价.中国临床药理学杂[2]李明成，<span class="g-font-color green">吴方红，文静，等.紫杉醇联合卡铂治疗晚期与复发性宫颈癌的疗效及安全性.</span>中国医院用药评价与分析，2016，[3]陈永发，杨文，潘兴喜，等.紫杉醇、奈                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术期刊）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《伊立替康联合顺铂与紫杉醇联合顺铂治疗宫颈癌的临床效果观察》<br><b>作者：</b>黄倩羽 潘毅贞<br><b>作者单位：</b>518000,北京大学深圳医院妇产科；518000,北京大学深圳医院肿瘤内科<br><b>参考文献：</b>10篇<br><b>页码：</b>P110—P111<br><b>页数：</b>2页<br><b>期刊名称：</b>《中国现代药物应用》<br><b>出版时间：</b>2017年12期<br><b>ISSN：</b>1673-9523<br><b>关键词：</b>宫颈癌 顺铂 伊立替康 紫杉醇 疗效<br><b>摘要：</b>目的 探索及分析针对宫颈癌患者分别以伊立替康联合顺铂方案和紫杉醇联合顺铂方案治疗的效果.方法 100例宫颈癌患者,随机分成参考组和治疗组,各50例.参考组患者给予紫杉醇联合顺铂方案治疗;治疗组患者给予伊立替康联合顺铂方案治疗.比较两组患者治疗效果、肿瘤直径及不良反应发生情况.结果 治疗组总有效率为90.0%,高于参考组的70.0%,差异具有统计学意义(P&lt;0.05).治疗后两组患者肿瘤直径均小于治疗前,且治疗组短于参考组,差异具有统计学意义(P&lt;0.05).治疗组各不良反应发生率均低于参考组,差异具有统计学意义(P&lt;0.05).结论 针对宫颈癌患者以伊立替康联合顺铂方案治疗的临床价值较紫杉醇联合顺铂方案明显更为优秀,值得借鉴.
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">8</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">40%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">回顾<span class="g-underline-text">性</span>分析替吉奥单药或<span class="g-underline-text">联合</span>用药<span class="g-underline-text">在</span><span class="g-underline-text">复发</span><span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span><span class="g-underline-text">癌</span>治疗中<span class="g-underline-text">的</span><span class="g-underline-text">疗效</span>及<span class="g-underline-text">安全</span><span class="g-underline-text">性</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">白蛋白结合型紫杉醇<span class="g-underline-text">联合</span>奈达铂<span class="g-underline-text">在</span>晚期、<span class="g-underline-text">复发</span>转移<span class="g-underline-text">性</span><span class="g-underline-text">宫颈</span><span class="g-underline-text">癌</span><span class="g-underline-text">的</span>近期<span class="g-underline-text">疗效</span>和<span class="g-underline-text">安全</span><span class="g-underline-text">性</span>。</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            效率为46．3%。而白蛋白结合型紫杉醇联合奈达铂方案在宫颈癌中的临床研究尚未见报道，因此我们进行了这项单中心、前瞻性、开放性临床研究，以评价<span class="g-font-color green">白蛋白结合型紫杉醇联合奈达铂在晚期、复发转移性宫颈癌的近期疗效和安全性。</span>目的：评价白蛋白结合型紫杉醇联合奈达铂方案在晚期、复发转移性宫颈癌的近期                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《白蛋白结合型紫杉醇联合奈达铂在晚期、复发转移性宫颈癌中的Ⅱ期临床研究》<br><b>作者：</b>曾靖<br><b>学科专业：</b>肿瘤学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>张蓉<br><b>学位授予单位：</b>中国医学科学院<br><b>学位年度：</b>2014
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
            
        <!--语句修改建议-->
        <span id="modify_suggest"></span>
        <div id="advice">
            <div class="g-line-row"></div>
            <div class="paper-txt P30 PB0">
                <div class="paper-section">
                    <p class="g-font-s16 font-bold g-font-color green MB10">该句修改建议（轻度相似，请酌情修改）</p>
                    <span class="g-font-color green">回顾<span class="g-font-color red">性</span>分析<span class="g-font-color red">替</span>吉奥<span class="g-font-color red">单</span>药或<span class="g-font-color red">联合</span>用药在<span class="g-font-color red">复发</span><span class="g-font-color red">性</span><span class="g-font-color red">宫颈</span><span class="g-font-color red">癌</span><span class="g-font-color red">治疗</span><span class="g-font-color red">中</span>的<span class="g-font-color red">疗效</span>及<span class="g-font-color red">安全</span><span class="g-font-color red">性</span>。</span>
                    <div class="MT10">
                        <p class="font-bold">同义词：</p>
                        <ul class="local-source-detail">
                            <li class="g-font-color green"><span class="g-font-color red">安全：</span>宁静  安好 安适 恬静</li><li class="g-font-color green"><span class="g-font-color red">治疗：</span>医治 治病 看病 医疗  诊疗 诊治 临床</li><li class="g-font-color green"><span class="g-font-color red">复发：</span>再现 重现  复出</li><li class="g-font-color green"><span class="g-font-color red">宫颈：</span>子</li><li class="g-font-color green"><span class="g-font-color red">联合：</span>结合  连系 连络</li>
                        </ul>

                    </div>
                </div>
            </div>
        </div>
    </div>
    <div class="back-to-top text-center">
        <a href="#gototop" class="font-bold g-font-color green">回到顶部</a>
    </div>
    <div class="paper-footer">
        <p>检测报告由<a href="http://www.paperpass.com/" target="_black">PaperPass</a>文献相似度检测系统生成</p>
        <p>Copyright © 2007-2018 PaperPass</p>
    </div>
</div>
</body>
<script type="text/javascript" src="../js/jquery.min.js"></script>
<script type="text/javascript" src="../js/Lib.js"></script>
<script type="text/javascript">
    (function(System,$){
        var tab = System.Paper.tab();
        var $advice = null;
        function run(){
            var i = 0;
            $advice.show();
            tab.call(this,{callback:function(){
                var $num = $(this).find('.chapter-num');
                if($num.length>0){
                    i++;
                    $num.text(i);
                }
            }});
            //没有内容时同时不显示该句修改建议
            if(0 === i){$advice.hide();}
        }
        $(function(){
            $advice = $('#advice');
            $(document).on('click','[tab-a="ul"] li',function(){
                run.call(this);
            });
            $(document).on('click','[tab-b="ul"] li',function(){
                run.call(this);
            });
        });
    })(Report,jQuery);


</script>
</html>
